{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:15:43Z","timestamp":1794014143406,"version":"4.8.0"},"reference-count":42,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Agence Nationale de Recherche\/French National Research Agency, Franch","award":["ANR21-RAR4-0003-04"],"award-info":[{"award-number":["ANR21-RAR4-0003-04"]}]},{"name":"European Joint Programme","award":["825575"],"award-info":[{"award-number":["825575"]}]},{"DOI":"10.13039\/501100000030","name":"Institute of Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Federal Ministry of Education and Research, Germany","award":["01GM2110"],"award-info":[{"award-number":["01GM2110"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,7,19]]},"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Friedreich ataxia (FA) is the most common hereditary ataxia in Europe, characterised by progressively worsening movement and speech impairments with a typical onset before the age of 25 years. The symptoms affect the patients\u2019 health-related quality of life (HRQoL) and psychosocial health. FA leads to an increasing need for care, associated with an economic burden. Little is known about the impact of FA on daily lives and HRQoL. To fill that gap, we will assess patient-reported, psychosocial and economic outcomes using momentary data assessment via a mobile health application (app).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The PROFA Study is a prospective observational study. Patients with FA (n=200) will be recruited at six European study centres (Germany, France and Austria). We will interview patients at baseline in the study centre and subsequently assess the patients\u2019 health at home via mobile health app. Patients will self-report ataxia severity, HRQoL, speech and hearing disabilities, coping strategies and well-being, health services usage, adverse health events and productivity losses due to informal care on a daily to monthly basis on the app for 6\u2009months. Our study aims to (1) validate measurements of HRQoL and psychosocial health, (2) assess the usability of the mobile health app, and (3) use descriptive and multivariate statistics to analyse patient-reported and economic outcomes and the interaction effects between these outcomes. Insights into the app\u2019s usability could be used for future studies using momentary data assessments to measure outcomes of patients with FA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval has been obtained from the Ethics Committee of the University Medicine of Greifswald, (BB096\/22a, 26 October 2022) and from all local ethics committees of the participating study sites. Findings of the study will be published in peer-reviewed journals, presented at relevant international\/national congresses and disseminated to German and French Patient Advocacy Organizations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Registry (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05943002\">NCT05943002<\/jats:ext-link>\n                      ); Pre-results.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-075736","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T12:51:02Z","timestamp":1690894262000},"page":"e075736","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Patient-reported, health economic and psychosocial outcomes in patients with Friedreich ataxia (PROFA): protocol of an observational study using momentary data assessments via mobile health app"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct05943002","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05943002","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4486-8632","authenticated-orcid":false,"given":"Maresa","family":"Buchholz","sequence":"first","affiliation":[{"name":"Translational Health Care Research, German Center for Neurodegenerative Diseases, Site Rostock\/Greifswald, Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Weber","sequence":"additional","affiliation":[{"name":"Translational Health Care Research, German Center for Neurodegenerative Diseases, Site Rostock\/Greifswald, Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Borel","sequence":"additional","affiliation":[{"name":"Paris Brain Institute (ICM - Institut du Cerveau), INSERM, CNRS, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Sorbonne University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Sayah","sequence":"additional","affiliation":[{"name":"Paris Brain Institute (ICM - Institut du Cerveau), INSERM, CNRS, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Sorbonne University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Durr","sequence":"additional","affiliation":[{"name":"Paris Brain Institute (ICM - Institut du Cerveau), INSERM, CNRS, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Sorbonne University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3454-6266","authenticated-orcid":false,"given":"Feng","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg B","family":"Schulz","sequence":"additional","affiliation":[{"name":"Department of Neurology, RWTH Aachen University, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Reetz","sequence":"additional","affiliation":[{"name":"Department of Neurology, RWTH Aachen University, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Boesch","sequence":"additional","affiliation":[{"name":"Clinical Department of Neurology, Medical University Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klopstock","sequence":"additional","affiliation":[{"name":"Friedrich-Baur-Institut, Department of Neurology, Ludwig Maximilians University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Karin","sequence":"additional","affiliation":[{"name":"Friedrich-Baur-Institut, Department of Neurology, Ludwig Maximilians University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Sch\u00f6ls","sequence":"additional","affiliation":[{"name":"Hertie Institute for Clinical Brain Research and Center of Neurology, University Hospital T\u00fcbingen, Tubingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Grobe-Einsler","sequence":"additional","affiliation":[{"name":"German Center for Neurodegenerative Diseases, Bonn, Germany"},{"name":"Department of Neurology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klockgether","sequence":"additional","affiliation":[{"name":"German Center for Neurodegenerative Diseases, Bonn, Germany"},{"name":"Department of Neurology, University Hospital Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin Haf","family":"Davies","sequence":"additional","affiliation":[{"name":"Aparito Ltd, Wrexham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Schmeder","sequence":"additional","affiliation":[{"name":"Association Fran\u00e7aise de l'Ataxie de Friedreich, Hirson, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Nadke","sequence":"additional","affiliation":[{"name":"Deutsche Heredo-Ataxie-Gesellschaft, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3425-0089","authenticated-orcid":false,"given":"Bernhard","family":"Michalowsky","sequence":"additional","affiliation":[{"name":"Translational Health Care Research, German Center for Neurodegenerative Diseases, Site Rostock\/Greifswald, Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"key":"2025121604464926000_13.8.e075736.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2009.26"},{"key":"2025121604464926000_13.8.e075736.2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.37.1.1"},{"key":"2025121604464926000_13.8.e075736.3","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5254.1423"},{"key":"2025121604464926000_13.8.e075736.4","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/104.3.589"},{"key":"2025121604464926000_13.8.e075736.5","article-title":"Pharmacological treatments for friedreich ataxia","volume":"2016","author":"Kearney","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121604464926000_13.8.e075736.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2010.01.002"},{"key":"2025121604464926000_13.8.e075736.7","doi-asserted-by":"crossref","first-page":"116642","DOI":"10.1016\/j.jns.2019.116642","article-title":"Health related quality of life in friedreich ataxia in a large heterogeneous cohort","volume":"410","author":"Xiong","year":"2020","journal-title":"J Neurol Sci"},{"key":"2025121604464926000_13.8.e075736.8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11136-019-02311-9","article-title":"Health-related quality of life and depressive symptoms in friedreich ataxia","volume":"29","author":"P\u00e9rez-Flores","year":"2020","journal-title":"Qual Life Res"},{"key":"2025121604464926000_13.8.e075736.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2008.05.009"},{"key":"2025121604464926000_13.8.e075736.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2007.01881.x"},{"key":"2025121604464926000_13.8.e075736.11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/eurpub\/ckz073","article-title":"The financial burden of non-communicable diseases in the European Union: a systematic review","volume":"30","author":"Vandenberghe","year":"2020","journal-title":"Eur J Public Health"},{"key":"2025121604464926000_13.8.e075736.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012527","article-title":"Cost burden of type 2 diabetes in Germany: results from the population-based KORA studies","volume":"6","author":"Ulrich","year":"2016","journal-title":"BMJ Open"},{"key":"2025121604464926000_13.8.e075736.13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2013.00066","article-title":"Burden of friedreich\u2019s ataxia to the patients and healthcare systems in the United States and Canada","volume":"4","author":"Polek","year":"2013","journal-title":"Front Pharmacol"},{"key":"2025121604464926000_13.8.e075736.14","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-8-38","article-title":"Impact of friedreich\u2019s ataxia on health-care resource utilization in the United Kingdom and Germany","volume":"8","author":"Giunti","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"2025121604464926000_13.8.e075736.15","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12091184","article-title":"Caregiver burden in movement disorders and neurodegenerative diseases: editorial","volume":"12","author":"Klietz","year":"2022","journal-title":"Brain Sci"},{"key":"2025121604464926000_13.8.e075736.16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12311-019-01084-8","article-title":"Speech and language disorders in friedreich ataxia: highlights on phenomenology, assessment, and therapy","volume":"19","author":"Schirinzi","year":"2020","journal-title":"Cerebellum"},{"key":"2025121604464926000_13.8.e075736.17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.neuroscience.2010.09.013","article-title":"Successful treatment of auditory perceptual disorder in individuals with friedreich ataxia","volume":"171","author":"Rance","year":"2010","journal-title":"Neuroscience"},{"key":"2025121604464926000_13.8.e075736.18","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70321-7"},{"key":"2025121604464926000_13.8.e075736.19","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-014-0176-2"},{"key":"2025121604464926000_13.8.e075736.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00231.x"},{"key":"2025121604464926000_13.8.e075736.21","doi-asserted-by":"crossref","DOI":"10.2196\/15588","article-title":"Benefits and disadvantages of electronic patient-reported outcome measures: systematic review","volume":"3","author":"Meirte","year":"2020","journal-title":"JMIR Perioper Med"},{"key":"2025121604464926000_13.8.e075736.22","doi-asserted-by":"publisher","DOI":"10.3109\/07853890109002087"},{"key":"2025121604464926000_13.8.e075736.23","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28670"},{"key":"2025121604464926000_13.8.e075736.24","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000219042.60538.92"},{"key":"2025121604464926000_13.8.e075736.25","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-012-0421-3"},{"key":"2025121604464926000_13.8.e075736.26","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000371","article-title":"Psychometric properties of the friedreich ataxia rating scale","volume":"5","author":"Rummey","year":"2019","journal-title":"Neurol Genet"},{"issue":"Pt 4","key":"2025121604464926000_13.8.e075736.27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/brain\/121.4.561","article-title":"The cerebellar cognitive affective syndrome","volume":"121 (Pt 4)","author":"Schmahmann","year":"1998","journal-title":"Brain"},{"key":"2025121604464926000_13.8.e075736.28","doi-asserted-by":"crossref","DOI":"10.1186\/s42466-020-00071-3","article-title":"Validation of a german version of the cerebellar cognitive affective\/ schmahmann syndrome scale: preliminary version and study protocol","volume":"2","author":"Thieme","year":"2020","journal-title":"Neurol Res Pract"},{"key":"2025121604464926000_13.8.e075736.29","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28478"},{"key":"2025121604464926000_13.8.e075736.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00106-003-0909-8"},{"key":"2025121604464926000_13.8.e075736.31","first-page":"307","article-title":"The voice handicap index: impact of the translation in french on the validation","volume":"125","author":"Woisard","year":"2004","journal-title":"Rev Laryngol Otol Rhinol (Bord)"},{"key":"2025121604464926000_13.8.e075736.32","doi-asserted-by":"publisher","DOI":"10.3109\/14992027.2013.781278"},{"key":"2025121604464926000_13.8.e075736.33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14670100.2019.1707993","article-title":"Self-assessment of daily hearing function for implant recipients: a comparison of mean total scores for the speech spatial qualities of hearing scale (SSQ49) with the SSQ12","volume":"21","author":"Wyss","year":"2020","journal-title":"Cochlear Implants Int"},{"key":"2025121604464926000_13.8.e075736.34","doi-asserted-by":"publisher","DOI":"10.3109\/14992027.2012.690078"},{"key":"2025121604464926000_13.8.e075736.35","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.725080","article-title":"French version of the antiphasic digits-in-noise test for smartphone hearing screening","volume":"9","author":"Ceccato","year":"2021","journal-title":"Front Public Health"},{"key":"2025121604464926000_13.8.e075736.36","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-016-0778-8"},{"key":"2025121604464926000_13.8.e075736.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2016.08.050"},{"key":"2025121604464926000_13.8.e075736.38","doi-asserted-by":"publisher","DOI":"10.1002\/per.546"},{"key":"2025121604464926000_13.8.e075736.39","first-page":"507","article-title":"Multidimensional assessment of coping: validation of the brief COPE among french population","volume":"29","author":"Muller","year":"2003","journal-title":"Encephale"},{"key":"2025121604464926000_13.8.e075736.40","first-page":"46","article-title":"FIMA--questionnaire for health-related resource use in an elderly population: development and pilot study","volume":"77","author":"Seidl","year":"2015","journal-title":"Gesundheitswesen"},{"key":"2025121604464926000_13.8.e075736.41","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jalz.2012.06.008","article-title":"Application of resource utilization in dementia (RUD) instrument in a global setting","volume":"9","author":"Wimo","year":"2013","journal-title":"Alzheimers Dement"},{"key":"2025121604464926000_13.8.e075736.42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1744-9081-6-65","article-title":"Exploration of transitional life events in individuals with friedreich ataxia: implications for genetic counseling","volume":"6","author":"White","year":"2010","journal-title":"Behav Brain Funct"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-075736","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:48:23Z","timestamp":1765889303000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-075736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8,1]]},"published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1136\/bmjopen-2023-075736"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-075736","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]}}}